Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-24-089279
Filing Date
2024-08-01
Accepted
2024-08-01 16:10:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 abio_424b3_20240801.htm 424B3 1218537
2 GRAPHIC img225960569_0.jpg GRAPHIC 18292
  Complete submission text file 0000950170-24-089279.txt   1245107
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279387 | Film No.: 241166717
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)